During a lengthy five-year bankruptcy of the pharmaceutical distributor Grama LLC, the bankruptcy manager challenged transactions with suppliers - large international pharmaceutical companies. Worst-hit was AstraZeneca Pharmaceuticals obliged to return the bankrupt distributor 266 million rubles. Lidings represents the company since 2019.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 3.02 Mb

Lidings demonstrates new achievements and takes advanced positions in the rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. Results of the new research published in a special supplement to Kommersant as of March 17, 2021.

March 11, 2021 Pravo.ru-300 released its individual rating of lawyers. Based on the new rating Lidings managing partner Andrey Zelenin, partners Stepan Guzey and Alexander Popleyuk take top positions in key practice areas.

Lidings’ managing partner Andrey Zelenin heading the firm’s Pharmaceuticals and Healthcare industry practice and partner Boris Malakhov, Head of the Intellectual Property practice of the firm, run a special webinar on the key market developments in the healthcare and life sciences sector in Russia.

Country-specific Q&A provides an overview of Pharmaceutical Advertising laws and regulations applicable in Russia.

• pdf, 3.18 Mb

The Ministry of Healthcare of the Russian Federation approved the "Procedure for monitoring the safety of medical devices" (hereinafter referred to as the "Procedure"), which will come into force on January 1, 2021, and will be valid until January 1, 2027.

The new rules on the medicines interchangeability No. 1360 (hereinafter – the Rules) enacted by the Russian Government have entered into force on 9 September 2020.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 295.29 kb